Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CartiLife Autologous Chondrocyte Implantation vs Microfracture for Knee Chondral Defects (Phase II)
KCT0001577Phase 2Recruiting
- Sponsor
- MCTT
- Start
- Feb 2014
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CartiLife in cartilage defect of knee, knee osteoarthritis (OA), chondral knee defect, sponsored by MCTT. Started Feb 2014; status: recruiting.
02
Drugs
CartiLife
03
Conditions
cartilage defect of kneeknee osteoarthritis (OA)chondral knee defect
Beyond the preview
Go deeper on KCT0001577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001577.